Human β-defensin 3 induces STAT1 phosphorylation, tyrosine phosphatase activity, and cytokine synthesis in T cells

Journal of Leukocyte Biology

Volumn 94, Issue 3, 2013, Pages 459-471

  Meisch, Jeffrey P ^a   Vogel, Ryan M ^a   Schlatzer, Daniela M ^a   Li, Xiaolin ^a   Chance, Mark R ^a   Levine, Alan D ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antimicrobial peptides; IFN ; IL 10; IL 2; Signal transduction; T lymphocyte

Indexed keywords

BETA DEFENSIN 3; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN TYROSINE PHOSPHATASE SHP 2; STAT1 PROTEIN; T LYMPHOCYTE RECEPTOR;

ARTICLE; CELL LINEAGE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOBLAST; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIMICROBIAL PEPTIDES; IFN-Γ; IL-10; IL-2; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTIGENS, CD28; BETA-DEFENSINS; CELL LINE; CHROMATOGRAPHY, LIQUID; CYTOKINES; HUMANS; INTERFERON-GAMMA; JANUS KINASES; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; PROTEIN TYROSINE PHOSPHATASES; STAT1 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TANDEM MASS SPECTROMETRY;

EID: 84883250175     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0612300     Document Type: Article

References (58)

1. Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms. Nature 415, 389-395.
2. Ganz, T. (2003) Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3, 710-720.
3. Hollox, E. J., Barber, J. C., Brookes, A. J., Armour, J. A. (2008) Defensins and the dynamic genome: what we can learn from structural variation at human chromosome band 8p23.1. Genome Res. 18, 1686-1697.
4. Harder, J., Bartels, J., Christophers, E., Schroder, J. M. (2001) Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276, 5707-5713.
5. Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y. H., Homey, B., Cao, W., Su, B., Nestle, F. O., Zal, T., Mellman, I., Schroder, J. M., Liu, Y. J., Gilliet, M. (2007) Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449, 564-569.
6. Yu, J., Mookherjee, N., Wee, K., Bowdish, D. M., Pistolic, J., Li, Y., Rehaume, L., Hancock, R. E. (2007) Host defense peptide LL-37, in synergy with inflammatory mediator IL-1β, augments immune responses by multiple pathways. J. Immunol. 179, 7684-7691.
7. Grigat, J., Soruri, A., Forssmann, U., Riggert, J., Zwirner, J. (2007) Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human α-defensin family. J. Immunol. 179, 3958-3965.
8. Soruri, A., Grigat, J., Forssmann, U., Riggert, J., Zwirner, J. (2007) β-Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved. Eur. J. Immunol. 37, 2474-2486.
9. Taylor, K., Clarke, D. J., McCullough, B., Chin, W., Seo, E., Yang, D., Oppenheim, J., Uhrin, D., Govan, J. R., Campopiano, D. J., MacMillan, D., Barran, P., Dorin, J. R. (2008) Analysis and separation of residues important for the chemoattractant and antimicrobial activities of betadefensin 3. J. Biol. Chem. 283, 6631-6639.
10. Chen, X., Niyonsaba, F., Ushio, H., Hara, M., Yokoi, H., Matsumoto, K., Saito, H., Nagaoka, I., Ikeda, S., Okumura, K., Ogawa, H. (2007) Antimicrobial peptides human β-defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability. Eur. J. Immunol. 37, 434-444.
11. Niyonsaba, F., Ushio, H., Nagaoka, I., Okumura, K., Ogawa, H. (2005) The human β-defensins (-1,-2,-3,-4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes. J. Immunol. 175, 1776-1784.
12. Niyonsaba, F., Ushio, H., Nakano, N., Ng, W., Sayama, K., Hashimoto, K., Nagaoka, I., Okumura, K., Ogawa, H. (2007) Antimicrobial peptides human β-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J. Invest. Dermatol. 127, 594-604.
13. Jin, G., Kawsar, H. I., Hirsch, S. A., Zeng, C., Jia, X., Feng, Z., Ghosh, S. K., Zheng, Q. Y., Zhou, A., McIntyre, T. M., Weinberg, A. (2010) An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis. PLoS One 5, e10993.
14. Rohrl, J., Yang, D., Oppenheim, J. J., Hehlgans, T. (2010) Human β-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J. Immunol. 184, 6688-6694.
15. Candille, S. I., Kaelin, C. B., Cattanach, B. M., Yu, B., Thompson, D. A., Nix, M. A., Kerns, J. A., Schmutz, S. M., Millhauser, G. L., Barsh, G. S. (2007) A-defensin mutation causes black coat color in domestic dogs. Science 318, 1418-1423.
16. Funderburg, N., Lederman, M. M., Feng, Z., Drage, M. G., Jadlowsky, J., Harding, C. V., Weinberg, A., Sieg, S. F. (2007) Human-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc. Natl. Acad. Sci. USA 104, 18631-18635.
17. Yang, D., Chertov, O., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., Anderson, M., Schroder, J. M., Wang, J. M., Howard, O. M., Oppenheim, J. J. (1999) β-Defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286, 525-528.
18. Agerberth, B., Charo, J., Werr, J., Olsson, B., Idali, F., Lindbom, L., Kiessling, R., Jornvall, H., Wigzell, H., Gudmundsson, G. H. (2000) The human antimicrobial and chemotactic peptides LL-37 and β-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96, 3086-3093.
19. Feng, Z., Dubyak, G. R., Lederman, M. M., Weinberg, A. (2006) Cutting edge: human β defensin 3-a novel antagonist of the HIV-1 coreceptor CXCR4. J. Immunol. 177, 782-786.
20. Rivera Reyes, B. M., Danese, S., Sans, M., Fiocchi, C., Levine, A. D. (2005) Redox equilibrium in mucosal T cells tunes the intestinal TCR signaling threshold. J. Immunol. 175, 2158-2166.
21. Wei, L., Laurence, A., O'Shea, J. J. (2008) New insights into the roles of Stat5a/b and Stat3 in T cell development and differentiation. Semin. Cell. Dev. Biol. 19, 394-400.
22. Kisseleva, T., Bhattacharya, S., Braunstein, J., Schindler, C. W. (2002) Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285, 1-24.
23. Schindler, C., Levy, D. E., Decker, T. (2007) JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282, 20059-20063.
24. Shuai, K., Liu, B. (2003) Regulation of JAK-STAT signalling in the immune system. Nat. Rev. Immunol. 3, 900-911.
25. Meisch, J. P., Nishimura, M., Vogel, R. M., Sung, H. C,. Bednarchik, B. A., Ghosh, S. K., Fu, P., McCormick, T., Weinberg, A., Levine, A. D. (2013) Human β-defensin 3 peptide is increased and redistributed in Crohn's ileitis. Inflamm. Bowel Dis. 19, 942-953.
26. Diamond, G., Beckloff, N., Weinberg, A., Kisich, K. O. (2009) The roles of antimicrobial peptides in innate host defense. Curr. Pharm. Des. 15, 2377-2392.
27. Pelletier, S., Duhamel, F., Coulombe, P., Popoff, M. R., Meloche, S. (2003) Rho family GTPases are required for activation of Jak/STAT signaling by G protein-coupled receptors. Mol. Cell. Biol. 23, 1316-1333.
28. Vila-Coro, A. J., Rodriguez-Frade, J. M., Martin De Ana, A., Moreno-Ortiz, M. C., Martinez, A. C., Mellado, M. (1999) The chemokine SDF-1β triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 13, 1699-1710.
29. Biswas, S. K., Sodhi, A. (2002) Tyrosine phosphorylation-mediated signal transduction in MCP-1-induced macrophage activation: role for receptor dimerization, focal adhesion protein complex and JAK/STAT pathway. Int. Immunopharmacol. 2, 1095-1107.
30. Lund, T. C., Garcia, R., Medveczky, M. M., Jove, R., Medveczky, P. G. (1997) Activation of STAT transcription factors by herpesvirus Saimiri Tip-484 requires p56lck. J. Virol. 71, 6677-6682.
31. You, M., Yu, D. H., Feng, G. S. (1999) Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol. Cell. Biol. 19, 2416-2424.
32. Wu, T. R., Hong, Y. K., Wang, X. D., Ling, M. Y., Dragoi, A. M., Chung, A. S., Campbell, A. G., Han, Z. Y., Feng, G. S., Chin, Y. E. (2002) SHP-2 is a dual-specificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei. J. Biol. Chem. 277, 47572-47580.
33. Ten Hoeve, J., de Jesus Ibarra-Sanchez, M., Fu, Y., Zhu, W., Tremblay, M., David, M., Shuai, K. (2002) Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol. Cell. Biol. 22, 5662-5668.
34. Kim, H., Hawley, T. S., Hawley, R. G., Baumann, H. (1998) Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells. Mol. Cell. Biol. 18, 1525-1533.
35. Ohtani, T., Ishihara, K., Atsumi, T., Nishida, K., Kaneko, Y., Miyata, T., Itoh, S., Narimatsu, M., Maeda, H., Fukada, T., Itoh, M., Okano, H., Hibi, M., Hirano, T. (2000) Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3-and SHP2-mediated signals in immune responses. Immunity 12, 95-105.
36. Aiyer, R. A., Serrano, L. E., Jones, P. P. (1986) Interferon-γ binds to high and low affinity receptor components on murine macrophages. J. Immunol. 136, 3329-3334.
37. Kamijo, R., Harada, H., Matsuyama, T., Bosland, M., Gerecitano, J., Shapiro, D., Le, J., Koh, S. I., Kimura, T., Green, S. J., et al. (1994) Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263, 1612-1615.
38. Stevens, T. L., Bossie, A., Sanders, V. M., Fernandez-Botran, R., Coffman, R. L., Mosmann, T. R., Vitetta, E. S. (1988) Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334, 255-258.
39. Barbi, J., Oghumu, S., Lezama-Davila, C. M., Satoskar, A. R. (2007) IFN-γ and STAT1 are required for efficient induction of CXC chemokine receptor 3 (CXCR3) on CD4+ but not CD8+ T cells. Blood 110, 2215-2216.
40. Ferber, I. A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D., Fathman, C. G. (1996) Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156, 5-7.
41. Vermeire, K., Heremans, H., Vandeputte, M., Huang, S., Billiau, A., Matthys, P. (1997) Accelerated collagen-induced arthritis in IFN-γ receptordeficient mice. J. Immunol. 158, 5507-5513.
42. Wang, Z., Hong, J., Sun, W., Xu, G., Li, N., Chen, X., Liu, A., Xu, L., Sun, B., Zhang, J. Z. (2006) Role of IFN-γ in induction of Foxp3 and conversion of CD4+ CD25+ T cells to CD4+ Tregs. J. Clin. Invest. 116, 2434-2441.
43. Pfitzner, E., Kliem, S., Baus, D., Litterst, C. M. (2004) The role of STATs in inflammation and inflammatory diseases. Curr. Pharm. Des. 10, 2839-2850.
44. Cox, J. H., Kljavin, N. M., Ramamoorthi, N., Diehl, L., Batten, M., Ghilardi, N. (2011) IL-27 promotes T cell-dependent colitis through multiple mechanisms. J. Exp. Med. 208, 115-123.
45. Klampfer, L., Huang, J., Sasazuki, T., Shirasawa, S., Augenlicht, L. (2003) Inhibition of interferon γ signaling by the short chain fatty acid butyrate. Mol. Cancer Res. 1, 855-862.
46. Sun, Y., Wu, X. X., Yin, Y., Gong, F. Y., Shen, Y., Cai, T. T., Zhou, X. B., Wu, X. F., Xu, Q. (2010) Novel immunomodulatory properties of cirsilineol through selective inhibition of IFN-γ signaling in a murine model of inflammatory bowel disease. Biochem. Pharmacol. 79, 229-238.
47. Kramer, O. H., Knauer, S. K., Greiner, G., Jandt, E., Reichardt, S., Guhrs, K. H., Stauber, R. H., Bohmer, F. D., Heinzel, T. (2009) A phosphorylation-acetylation switch regulates STAT1 signaling. Genes Dev. 23, 223-235.
48. Nelson, B. H. (2004) IL-2, regulatory T cells, and tolerance. J. Immunol. 172, 3983-3988.
49. Furtado, G. C., Curotto de Lafaille, M. A., Kutchukhidze, N., Lafaille, J. J. (2002) Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J. Exp. Med. 196, 851-857.
50. De la Rosa, M., Rutz, S., Dorninger, H., Scheffold, A. (2004) Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34, 2480-2488.
51. Kryczek, I., Wei, S., Vatan, L., Escara-Wilke, J., Szeliga, W., Keller, E. T., Zou, W. (2007) Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+ T cell pool IL-1 subverts IL-2-mediated suppression. J. Immunol. 179, 1423-1426.
52. Laurence, A., Tato, C. M., Davidson, T. S., Kanno, Y., Chen, Z., Yao, Z., Blank, R. B., Meylan, F., Siegel, R., Hennighausen, L., Shevach, E. M., O'Shea, J. J. (2007) Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26, 371-381.
53. Moore, K. W., O'Garra, A., de Waal Malefyt, R., Vieira, P., Mosmann, T. R. (1993) Interleukin-10. Ann. Rev. Immunol. 11, 165-190.
54. Bouma, G., Strober, W. (2003) The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3, 521-533.
55. Finnegan, A., Kaplan, C. D., Cao, Y., Eibel, H., Glant, T. T., Zhang, J. (2003) Collagen-induced arthritis is exacerbated in IL-10-deficient mice. Arthritis Res. Ther. 5, R18-R24.
56. Murai, M., Turovskaya, O., Kim, G., Madan, R., Karp, C. L., Cheroutre, H., Kronenberg, M. (2009) Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat. Immunol. 10, 1178-1184.
57. Chaudhry, A., Samstein, R. M., Treuting, P., Liang, Y., Pils, M. C., Heinrich, J. M., Jack, R. S., Wunderlich, F. T., Bruning, J. C., Muller, W., Rudensky, A. Y. (2011) Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34, 566-578.
58. Navid, F., Boniotto, M., Walker, C., Ahrens, K., Proksch, E., Sparwasser, T., Muller, W., Schwarz, T., Schwarz, A. (2012) Induction of regulatory T cells by a murine β-defensin. J. Immunol. 188, 735-743.